{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:24:02Z","timestamp":1792193042452,"version":"4.4.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T00:00:00Z","timestamp":1751155200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000761","name":"Imperial College London","doi-asserted-by":"publisher","award":["COMP360"],"award-info":[{"award-number":["COMP360"]}],"id":[{"id":"10.13039\/501100000761","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comprehensive Psychiatry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.comppsych.2025.152619","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T01:52:46Z","timestamp":1751421166000},"page":"152619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Single-dose (10\u00a0mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study"],"prefix":"10.1016","volume":"142","author":[{"given":"Luca","family":"Pellegrini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi A.","family":"Fineberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorcha","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria Frota Lisboa Pereira","family":"De Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Godfrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Peill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mairead","family":"Healy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus","family":"Rohani-Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakjun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Carhart-Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor W.","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Erritzoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.comppsych.2025.152619_bb0005","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/YCO.0b013e32816ebc8c","article-title":"Age of onset of mental disorders: a review of recent literature","volume":"20","author":"Kessler","year":"2007","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.comppsych.2025.152619_bb0010","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/mp.2008.94","article-title":"The epidemiology of obsessive-compulsive disorder in the national comorbidity survey replication","volume":"15","author":"Ruscio","year":"2010","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.comppsych.2025.152619_bb0015","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3109\/13651501.2013.777745","article-title":"Lifetime comorbidity of obsessive-compulsive disorder and sub-threshold obsessive-compulsive symptomatology in the community: impact, prevalence, socio-demographic and clinical characteristics","volume":"17","author":"Fineberg","year":"2013","journal-title":"Int J Psychiatry Clin Pract"},{"key":"10.1016\/j.comppsych.2025.152619_bb0020","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/YIC.0000000000000314","article-title":"Clinical advances in obsessive-compulsive disorder: a position statement by the international college of obsessive-compulsive spectrum disorders","volume":"35","author":"Fineberg","year":"2020","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.comppsych.2025.152619_bb0025","doi-asserted-by":"crossref","first-page":"784","DOI":"10.4088\/JCP.09m05911blu","article-title":"Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse","volume":"71","author":"Hollander","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.comppsych.2025.152619_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2023.152422","article-title":"A cost-of-illness analysis of the economic burden of obsessive-compulsive disorder in the United Kingdom","volume":"127","author":"Kochar","year":"2023","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.comppsych.2025.152619_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2021.152246","article-title":"Suicidality in patients with obsessive-compulsive and related disorders (OCRDs): a meta-analysis","volume":"108","author":"Pellegrini","year":"2021","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.comppsych.2025.152619_bb0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.eurpsy.2019.01.017","article-title":"Duration of untreated illness and response to SRI treatment in obsessive-compulsive disorder","volume":"58","author":"Albert","year":"2019","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.comppsych.2025.152619_bb0045","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1017\/S1461145711001829","article-title":"Evidence-based pharmacotherapy of obsessive-compulsive disorder","volume":"15","author":"Fineberg","year":"2012","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.comppsych.2025.152619_bb0050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cell.2020.03.020","article-title":"Psychedelic psychiatry\u2019s brave new world","volume":"181","author":"Nutt","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.comppsych.2025.152619_bb0055","first-page":"15","article-title":"Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder","author":"Szafoni","year":"2024","journal-title":"Front Psych"},{"key":"10.1016\/j.comppsych.2025.152619_bb0060","article-title":"Psychedelics, OCD and related disorders: a systematic review","volume":"41","author":"Graziosi","year":"2024","journal-title":"J Obsessive Compuls Relat Disord"},{"key":"10.1016\/j.comppsych.2025.152619_bb0065","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4088\/JCP.v67n1110","article-title":"Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder","volume":"67","author":"Moreno","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.comppsych.2025.152619_bb0070","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.comppsych.2025.152619_bb0075","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.comppsych.2025.152619_bb0080","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2023.14530","article-title":"Single-dose psilocybin treatment for major depressive disorder: a randomized clinical trial","volume":"330","author":"Raison","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.comppsych.2025.152619_bb0085","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/npp.2017.84","article-title":"The therapeutic potential of psychedelic drugs: past, present, and future","volume":"42","author":"Carhart-Harris","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.comppsych.2025.152619_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102799","article-title":"Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial","volume":"76","author":"Erritzoe","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.comppsych.2025.152619_bb0095","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s44220-023-00172-3","article-title":"Exploring mechanisms of psychedelic action using neuroimaging","volume":"2","author":"Erritzoe","year":"2024","journal-title":"Nat Ment Health"},{"key":"10.1016\/j.comppsych.2025.152619_bb0100","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00213-006-0457-5","article-title":"Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance","volume":"187","author":"Griffiths","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.comppsych.2025.152619_bb0105","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.q798","article-title":"Psilocybin for depression","author":"De Giorgi","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.comppsych.2025.152619_bb0110","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J Psychopharmacol (Oxf, Engl)"},{"key":"10.1016\/j.comppsych.2025.152619_bb0115","series-title":"Human Brain Changes After First Psilocybin Use","author":"Lyons","year":"2024"},{"key":"10.1016\/j.comppsych.2025.152619_bb0120","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/jamapsychiatry.2024.2546","article-title":"Adverse events in studies of classic psychedelics: a systematic review and meta-analysis","volume":"81","author":"Hinkle","year":"2024","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.comppsych.2025.152619_bb0125","article-title":"Manic episode following psilocybin use in a man with bipolar II disorder: a case report","volume":"14","author":"Halim","year":"2023","journal-title":"Front Psych"},{"key":"10.1016\/j.comppsych.2025.152619_bb0130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/02698811241232548","article-title":"Psychiatric risks for worsened mental health after psychedelic use","volume":"38","author":"Marrocu","year":"2024","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.comppsych.2025.152619_bb0135","series-title":"Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR)","author":"American Psychiatric Association","year":"2022"},{"key":"10.1016\/j.comppsych.2025.152619_bb0140","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jad.2015.06.005","article-title":"The prevalence and predictors of comorbid bipolar disorder and obsessive-compulsive disorder: a systematic review and meta-analysis","volume":"186","author":"Amerio","year":"2015","journal-title":"J Affect Disord"},{"key":"10.1016\/j.comppsych.2025.152619_bb0145","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1097\/CM9.0000000000002647","article-title":"Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity","volume":"136","author":"Du","year":"2023","journal-title":"Chin Med J (Engl)"},{"issue":"Suppl. 20","key":"10.1016\/j.comppsych.2025.152619_bb0150","first-page":"22","article-title":"The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.comppsych.2025.152619_bb0155","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.comppsych.2025.152619_bb0160","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.comppsych.2025.152619_bb0165","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1017\/S0033291723003653","article-title":"Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression","volume":"54","author":"Szigeti","year":"2024","journal-title":"Psychol Med"},{"key":"10.1016\/j.comppsych.2025.152619_bb0170","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0005-7916(00)00012-4","article-title":"Psychometric properties of the credibility\/expectancy questionnaire","volume":"31","author":"Devilly","year":"2000","journal-title":"J Behav Ther Exp Psychiatry"},{"key":"10.1016\/j.comppsych.2025.152619_bb0175","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1017\/S1355617798455073","volume":"4","author":"Robbins","year":"1998","journal-title":"J Int Neuropsychol Soc"},{"key":"10.1016\/j.comppsych.2025.152619_bb0180","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1176\/ajp.2007.164.2.335","article-title":"Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive-compulsive disorder","volume":"164","author":"Chamberlain","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.comppsych.2025.152619_bb0185","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.brat.2008.04.002","article-title":"Incompleteness and harm avoidance in OCD symptom dimensions","volume":"46","author":"Ecker","year":"2008","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.comppsych.2025.152619_bb0190","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyae057","article-title":"Psychedelics for the treatment of obsessive-compulsive disorder: efficacy and proposed mechanisms","volume":"27","author":"Collins","year":"2024","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.comppsych.2025.152619_bb0195","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/jox12010004","article-title":"Psilocybin for treating psychiatric disorders: a psychonaut legend or a promising therapeutic perspective?","volume":"12","author":"Coppola","year":"2022","journal-title":"J Xenobiotics"},{"key":"10.1016\/j.comppsych.2025.152619_bb0200","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1073\/pnas.1119598109","article-title":"Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin","volume":"109","author":"Carhart-Harris","year":"2012","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.comppsych.2025.152619_bb0205","article-title":"Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive\u2013compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial","volume":"14","author":"Ching","year":"2023","journal-title":"Front Psych"},{"key":"10.1016\/j.comppsych.2025.152619_bb0210","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s44220-024-00298-y","article-title":"Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression","volume":"2","author":"Deco","year":"2024","journal-title":"Nat Ment Health"},{"key":"10.1016\/j.comppsych.2025.152619_bb0215","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41591-022-01744-z","article-title":"Increased global integration in the brain after psilocybin therapy for depression","volume":"28","author":"Daws","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.comppsych.2025.152619_bb0220","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jpsychires.2020.04.002","article-title":"Exploring response inhibition and error monitoring in obsessive-compulsive disorder","volume":"126","author":"Silveira","year":"2020","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.comppsych.2025.152619_bb0225","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00213-017-4754-y","article-title":"Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression","volume":"235","author":"Stroud","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.comppsych.2025.152619_bb0230","first-page":"164","article-title":"Effectiveness treatment ERP on obsessive \u2013 compulsive disorder (OCD)","author":"Maleki","year":"2015","journal-title":"Int J Behav Res Psychol"},{"key":"10.1016\/j.comppsych.2025.152619_bb0235","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S2215-0366(24)00073-7","article-title":"Implementation research in mental health: meanings of the term real world","volume":"11","author":"Henderson","year":"2024","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.comppsych.2025.152619_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2022.152339","article-title":"Repetitive transcranial magnetic stimulation (r-TMS) and selective serotonin reuptake inhibitor-resistance in obsessive-compulsive disorder: a meta-analysis and clinical implications","volume":"118","author":"Pellegrini","year":"2022","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.comppsych.2025.152619_bb0265","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/15622970903418544","article-title":"Duration of untreated illness as a predictor of treatment response and remission in obsessive-compulsive disorder","volume":"11","author":"Dell\u2019Osso","year":"2010","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.comppsych.2025.152619_bb0270","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.biopsych.2019.01.017","article-title":"A randomized trial directly comparing ventral capsule and anteromedial subthalamic nucleus stimulation in obsessive-compulsive disorder: clinical and imaging evidence for dissociable effects","volume":"85","author":"Tyagi","year":"2019","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.comppsych.2025.152619_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2023.152371","article-title":"Feasibility, acceptability and practicality of transcranial stimulation in obsessive compulsive symptoms (FEATSOCS): a randomised controlled crossover trial","volume":"122","author":"Fineberg","year":"2023","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.comppsych.2025.152619_bb0280","series-title":"Depression: causes and treatment. 1st university of Pennsylvania press ed","author":"Beck","year":"1970"},{"key":"10.1016\/j.comppsych.2025.152619_bb0285","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004850-199606003-00015","article-title":"The measurement of disability","volume":"11","author":"Sheehan","year":"1996","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.comppsych.2025.152619_bb0290","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.comppsych.2025.152619_bb0315","article-title":"Psychedelics, OCD and related disorders: setting methodological strategies for future studies","volume":"45","author":"Leuzzi","year":"2025","journal-title":"J Obsessive Compuls Relat Disord"}],"container-title":["Comprehensive Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010440X25000471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010440X25000471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:38:29Z","timestamp":1762115909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010440X25000471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":55,"alternative-id":["S0010440X25000471"],"URL":"https:\/\/doi.org\/10.1016\/j.comppsych.2025.152619","relation":{},"ISSN":["0010-440X"],"issn-type":[{"value":"0010-440X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-dose (10\u00a0mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study","name":"articletitle","label":"Article Title"},{"value":"Comprehensive Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.comppsych.2025.152619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152619"}}